Phelps ME, Hoffman EJ, Mullani NA, et al. Application of annihilation coincidence detection to transaxial reconstruction tomography. J Nucl Med. 1975;16:210-224.
Ter-Pogossian MM, Phelps ME, Hoffman EJ, et al. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114:89-98.
Schwinger J. Source theory analysis of electron-positron annihilation experiments. Proc Natl Acad Sci USA. 1975;72:4725-4728.
Akeju O, Loggia ML, Catana C, et al. Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness. Elife. 2014;3:e04499, 1-23.
Langsjo JW, Alkire MT, Kaskinoro K, et al. Returning from oblivion: imaging the neural core of consciousness. J Neurosci. 2012;32:4935-4943.
Alkire MT, Gruver R, Miller J, et al. Neuroimaging analysis of an anesthetic gas that blocks human emotional memory. Proc Natl Acad Sci USA. 2008;105:1722-1727.
Skinbjerg M, Sibley DR, Javitch JA, et al. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction? Biochem Pharmacol. 2012;83:193-198.
Casteels C, Bormans G, Van LK. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain. Eur J Nucl Med Mol Imaging. 2010;37:1164-1173.
Xie G, Gunn RN, Dagher A, et al. PET quantification of muscarinic cholinergic receptors with [N-11C-methyl]-benztropine and application to studies of propofolinduced unconsciousness in healthy human volunteers. Synapse. 2004;51:91-101.
Sandiego CM, Jin X, Mulnix T, et al. Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11Cflumazenil in awake and anesthetized animals. J Nucl Med. 2013;54:1962-1968.
Zeng F, Mun J, Jarkas N, et al. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter. J Med Chem. 2009;52:62-73.
Stehouwer JS, Jarkas N, Zeng F, et al. Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(30-((Z)-2-haloethenyl) phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. J Med Chem. 2008;51:7788-7799.
Bishu S, Schmidt KC, Burlin TV, et al. Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-(11)C]leucine and PET in healthy male subjects. J Cereb Blood Flow Metab. 2009;29:1035-1047.
Laureys S, Owen AM, Schiff ND. Brain function in coma, vegetative state, and related disorders. Lancet Neurol. 2004;3:537-546.
Laureys S, Celesia GG, Cohadon F, et al. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Med. 2010;8:68.
Jennett B, Plum F. Persistent vegetative state after brain damage. A syndrome in search of a name. Lancet. 1972;1:734-737.
Giacino JT, Ashwal S, Childs N, et al. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002;58:349-353.
Bruno MA, Vanhaudenhuyse A, Thibaut A, et al. From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness. J Neurol. 2011;258:1373-1384.
Nizzi MC, Demertzi A, Gosseries O, et al. From armchair to wheelchair: how patients with a locked-in syndrome integrate bodily changes in experienced identity. Conscious Cogn. 2012;21:431-437.
Schnakers C, Vanhaudenhuyse A, Giacino J, et al. Diagnostic accuracy of the vegetative and minimally conscious state: clinical consensus versus standardized neurobehavioral assessment. BMC Neurol. 2009;9:35.
Gill-Thwaites H. Lotteries, loopholes and luck: misdiagnosis in the vegetative state patient. Brain Inj. 2006;20:1321-1328.
Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004;85:2020-2029.
Monti MM, Vanhaudenhuyse A, Coleman MR, et al. Willful modulation of brain activity in disorders of consciousness. N Engl J Med. 2010;362:579-589.
Stender J, Kupers R, Rodell A, et al. Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients. J Cereb Blood Flow Metab. 2015;35:58-65.
Laureys S, Lemaire C, Maquet P, et al. Cerebral metabolism during vegetative state and after recovery to consciousness. J Neurol Neurosurg Psychiatry. 1999;67:121.
Nakayama N, Okumura A, Shinoda J, et al. Relationship between regional cerebral metabolism and consciousness disturbance in traumatic diffuse brain injury without large focal lesions: an FDG-PET study with statistical parametric mapping analysis. J Neurol Neurosurg Psychiatry. 2006;77:856-862.
Thibaut A, Bruno MA, Chatelle C, et al. Metabolic activity in external and internal awareness networks in severely brain-damaged patients. J Rehabil Med. 2012;44:487-494.
Bruno MA, Majerus S, Boly M, et al. Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients. J Neurol. 2012;259:1087-1098.
Stender J, Gosseries O, Bruno MA, et al. Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study. Lancet. 2014;384:514-522.
Giacino JT, Fins JJ, Laureys S, et al. Disorders of consciousness after acquired brain injury: the state of the science. Nat Rev Neurol. 2014;10:99-114.
Laureys S, Faymonville ME, Degueldre C, et al. Auditory processing in the vegetative state. Brain. 2000;123(pt 8):1589-1601.
Laureys S, Faymonville ME, Peigneux P, et al. Cortical processing of noxious somatosensory stimuli in the persistent vegetative state. Neuroimage. 2002;17:732-741.
Boly M, Faymonville ME, Schnakers C, et al. Perception of pain in the minimally conscious state with PET activation: an observational study. Lancet Neurol. 2008;7:1013-1020.
Boly M, Faymonville ME, Peigneux P, et al. Auditory processing in severely brain injured patients: differences between the minimally conscious state and the persistent vegetative state. Arch Neurol. 2004;61:233-238.
Bonhomme V, Boveroux P, Vanhaudenhuyse A, et al. Linking sleep and general anesthesia mechanisms: this is no walkover. Acta Anaesthesiol Belg. 2011;62: 161-171.
Shulman RG, Hyder F, Rothman DL. Baseline brain energy supports the state of consciousness. Proc Natl Acad Sci USA. 2009;106:11096-11101.
Alkire MT. Quantitative EEG correlations with brain glucose metabolic rate during anesthesia in volunteers. Anesthesiology. 1998;89:323-333.
Schlunzen L, Juul N, Hansen KV, et al. Regional cerebral glucose metabolism during sevoflurane anaesthesia in healthy subjects studied with positron emission tomography. Acta Anaesthesiol Scand. 2010;54:603-609.
Fiset P, Paus T, Daloze T, et al. Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study. J Neurosci. 1999;19:5506-5513.
Alkire MT, Haier RJ, Barker SJ, et al. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology. 1995;82:393-403.
Alkire MT, Haier RJ, Shah NK, et al. Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anesthesia. Anesthesiology. 1997;86:549-557.
Alkire MT, Pomfrett CJ, Haier RJ, et al. Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology. 1999;90:701-709.
Schlunzen L, Juul N, Hansen KV, et al. Regional cerebral blood flow and glucose metabolism during propofol anaesthesia in healthy subjects studied with positron emission tomography. Acta Anaesthesiol Scand. 2012;56:248-255.
Kaisti KK, Langsjo JW, Aalto S, et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99:603-613.
Kaisti KK, Metsahonkala L, Teras M, et al. Effects of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography. Anesthesiology. 2002;96:1358-1370.
Schlunzen L, Vafaee MS, Cold GE, et al. Effects of subanaesthetic and anaesthetic doses of sevoflurane on regional cerebral blood flow in healthy volunteers. A positron emission tomographic study. Acta Anaesthesiol Scand. 2004;48:1268-1276.
Maksimow A, Kaisti K, Aalto S, et al. Correlation of EEG spectral entropy with regional cerebral blood flow during sevoflurane and propofol anaesthesia. Anaesthesia. 2005;60:862-869.
Rex S, Schaefer W, Meyer PH, et al. Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans. Anesthesiology. 2006;105:936-943.
Bonhomme V, Maquet P, Phillips C, et al. The effect of clonidine infusion on distribution of regional cerebral blood flow in volunteers. Anesth Analg. 2008;106:899-909. table.
Langsjo JW, Kaisti KK, Aalto S, et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99:614-623.
Bonhomme V, Fiset P, Meuret P, et al. Propofol anesthesia and cerebral blood flow changes elicited by vibrotactile stimulation: a positron emission tomography study. J Neurophysiol. 2001;85:1299-1308.
Xie G, Deschamps A, Backman SB, et al. Critical involvement of the thalamus and precuneus during restoration of consciousness with physostigmine in humans during propofol anaesthesia: a positron emission tomography study. Br J Anaesth. 2011;106:548-557.
Laitio RM, Langsjo JW, Aalto S, et al. The effects of xenon anesthesia on the relationship between cerebral glucose metabolism and blood flow in healthy subjects: a positron emission tomography study. Anesth Analg. 2009;108:593-600.
Rex S, Meyer PT, Baumert JH, et al. Positron emission tomography study of regional cerebral blood flow and flow-metabolism coupling during general anaesthesia with xenon in humans. Br J Anaesth. 2008;100:667-675.
Laitio RM, Kaisti KK, Laangsjo JW, et al. Effects of xenon anesthesia on cerebral blood flow in humans: a positron emission tomography study. Anesthesiology. 2007;106:1128-1133.
Bonhomme V, Boveroux P, Brichant JF, et al. Neural correlates of consciousness during general anesthesia using functional magnetic resonance imaging (fMRI). Arch Ital Biol. 2012;150:155-163.
Boveroux P, Vanhaudenhuyse A, Bruno MA, et al. Breakdown of within- and between-network resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. Anesthesiology. 2010;113:1038-1053.
Lee U, Ku S, Noh G, et al. Disruption of frontal-parietal communication by ketamine, propofol, and sevoflurane. Anesthesiology. 2013;118:1264-1275.
Palanca BJ, Mitra A, Larson-Prior L, et al. Resting-state functional magnetic resonance imaging correlates of sevoflurane-induced unconsciousness. Anesthesiology. 2015;123:346-356.
Guldenmund P, Demertzi A, Boveroux P, et al. Thalamus, brainstem and salience network connectivity changes during mild propofol sedation and unconsciousness. Brain Connect. 2013;3:273-285.
Lee U, Muller M, Noh GJ, et al. Dissociable network properties of anesthetic state transitions. Anesthesiology. 2011;114:872-881.
Lee U, Kim S, Noh GJ, et al. The directionality and functional organization of frontoparietal connectivity during consciousness and anesthesia in humans. Conscious Cogn. 2009;18:1069-1078.
White NS, Alkire MT. Impaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness. Neuroimage. 2003;19:402-411.
Sanders RD, Tononi G, Laureys S, et al. Unresponsiveness not equal unconsciousness. Anesthesiology. 2012;116:946-959.
Salmi E, Kaisti KK, Metsahonkala L, et al. Sevoflurane and propofol increase 11Cflumazenil binding to gamma-aminobutyric acidA receptors in humans. Anesth Analg. 2004;99:1420-1426.
Alkire MT, Haier RJ. Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane. Br J Anaesth. 2001;86:618-626.
Salmi E, Laitio RM, Aalto S, et al. Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans. Anesth Analg. 2008;106:129-134. table.
Cuaron J, Dunphy M, Rimner A. Role of FDG-PETscans in staging, response assessment, and follow-up care for non-small cell lung cancer. Front Oncol. 2012;2:208, 1-7.
Eubank WB, Mankoff DA. Current and future uses of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2004;34:224-240.
Rockall AG, Cross S, Flanagan S, et al. The role of FDG-PET/CT in gynaecological cancers. Cancer Imaging. 2012;12:49-65.
Krause BJ, Herrmann K, Wieder H, et al. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer. J Nucl Med. 2009;50(suppl 1):89S-96S.
Ott K, Weber WA, Lordick F, et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2006;24:4692-4698.
Agarwal A, Marcus C, Xiao J, et al. FDG PET/CT in the management of colorectal and anal cancers. AJR Am J Roentgenol. 2014;203:1109-1119.
Schwenzer NF, Pfannenberg AC. PET/CT, MR, and PET/MR in lymphoma and melanoma. Semin Nucl Med. 2015;45:322-331.
Kouijzer IJ, Bleeker-Rovers CP, Oyen WJ. FDG-PET in fever of unknown origin. Semin Nucl Med. 2013;43:333-339.
Glaudemans AW, De Vries EF, Galli F, et al. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013;2013:623036, 1-14.
Johnson DH, Via LE, Kim P, et al. Nuclear imaging: a powerful novel approach for tuberculosis. Nucl Med Biol. 2014;41:777-784.
Erba PA, Sollini M, Lazzeri E, et al. FDG-PET in cardiac infections. Semin Nucl Med. 2013;43:377-395.
Keidar Z, Nitecki S. FDG-PET in prosthetic graft infections. Semin Nucl Med. 2013;43:396-402.
Davison JM, Subramaniam RM, Surasi DS, et al. FDG PET/CT in patients with HIV. AJR Am J Roentgenol. 2011;197:284-294.
Heo R, Nakazato R, Kalra D, et al. Noninvasive imaging in coronary artery disease. Semin Nucl Med. 2014;44:398-409.
Anagnostopoulos C, Georgakopoulos A, Pianou N, et al. Assessment of myocardial perfusion and viability by positron emission tomography. Int J Cardiol. 2013;167: 1737-1749.
Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med. 2014;55:2003-2011.
Kiferle L, Politis M, Muraro PA, et al. Positron emission tomography imaging in multiple sclerosis-current status and future applications. Eur J Neurol. 2011;18: 226-231.
Jones T, Rabiner EA. The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab. 2012;32:1426-1454.
Lin SH, Lee LT, Yang YK. Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci. 2014;12:196-202.
Jalloh I, Carpenter KL, Helmy A, et al. Glucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings. Metab Brain Dis. 2015;30:615-632.
Irimia A, Van Horn JD. Functional neuroimaging of traumatic brain injury: advances and clinical utility. Neuropsychiatr Dis Treat. 2015;11:2355-2365.
Wilde EA, Bouix S, Tate DF, et al. Advanced neuroimaging applied to veterans and service personnel with traumatic brain injury: state of the art and potential benefits. Brain Imaging Behav. 2015;9:367-402.
Spadoni AD, Kosheleva E, Buchsbaum MS, et al. Neural correlates of malingering in mild traumatic brain injury: a positron emission tomography study. Psychiatry Res. 2015;233:367-372.
Yuh EL, Hawryluk GW, Manley GT. Imaging concussion: a review. Neurosurgery. 2014;75(suppl 4):S50-S63.
Barrio JR, Small GW, Wong KP, et al. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging. Proc Natl Acad Sci USA. 2015;112:E2039-E2047.
